IL4I1 attenuates myocardial infarction by inhibiting macrophage ferroptosis via the I3P/AHR/NRF2 signaling pathway
International Immunopharmacology · 2025-11 · 165 · 115393
DOI: 10.1016/j.intimp.2025.115393 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-11. Verfasst von Chen Dong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Hubei Key Labor…. Hauptthemen laut MEDLINE: Ferroptosis, Myocardial Infarction, Macrophages, Indoles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Innovative Research Group Project of the National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUNDS: As an immunometabolic enzyme, Interleukin-4 induced gene 1 (IL4I1) catalyzes aromatic amino acid degradation to modulate immune functions. Our prior work demonstrated that IL4I1 promotes anti-inflammatory macrophage polarization, thereby attenuating atherosclerosis progression-a key pathological precursor to myocardial infarction (MI). Despite this established role in plaque development, the functional significance of this immunometabolic enzyme in post-MI cardiac injury remains unexplored. METHODS: In murine MI models, we determined the cellular localization of IL4I1 expression. IL4I1-knockout (KO) and wild-type mice were evaluated for survival, cardiac function, fibrosis, inflammation, and ferroptosis markers. In vitro, cytoprotection by IL4I1 metabolites against hypoxia-induced ferroptosis was tested in macrophages. For therapeutic evaluation, IL4I1-KO mice received intraperitoneal indole-3-pyruvic acid (I3P). RESULTS: IL4I1 expression was significantly upregulated post-MI, peaking at day 3 and predominantly localized to macrophages. IL4I1-KO mice exhibited increased mortality, worsened cardiac dysfunction, aggravated fibrosis, amplified inflammation, and enhanced ferroptosis. In vitro, IL4I1-produced I3P rescued hypoxic macrophages by suppressing reactive oxygen species production, lipid peroxidation, and restoring FTH-1/GPX4 via AHR nuclear translocation. Mechanistically, I3P promoted AHR nuclear translocation, activating the NRF2 pathway. This protective effect was abolished by AHR inhibition. Critically, I3P administration rescued these impairments in IL4I1-KO mice. CONCLUSION: We identify a novel cardioprotective axis wherein macrophage-derived IL4I1 catalyzes the production of I3P, activating AHR-NRF2 signaling to suppress ferroptosis, thereby mitigating post-MI inflammation, adverse remodeling, and cardiac dysfunction. Targeting IL4I1 and I3P represents a promising therapeutic strategy for ischemic heart disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical C…
Förderung
- National Natural Science Foundation of China
- Innovative Research Group Project of the National Natural Science Foundation of China
Zitieren
APA
Dong, C., Shen, R., Ding, Y., Pan, C., Zhang, J., Yu, K., & Zeng, Q. (2025). IL4I1 attenuates myocardial infarction by inhibiting macrophage ferroptosis via the I3P/AHR/NRF2 signaling pathway. International Immunopharmacology, 165, 115393. https://doi.org/10.1016/j.intimp.2025.115393
Vancouver
Dong C, Shen R, Ding Y, Pan C, Zhang J, Yu K, et al. IL4I1 attenuates myocardial infarction by inhibiting macrophage ferroptosis via the I3P/AHR/NRF2 signaling pathway. International Immunopharmacology. 2025;165:115393. doi:10.1016/j.intimp.2025.115393
BibTeX
@article{Dong2025,
author = {Dong, Chen and Shen, Rui and Ding, Yan and Pan, Chengliang and Zhang, Jiangmei and Yu, Kunwu and Zeng, Qiutang},
title = {IL4I1 attenuates myocardial infarction by inhibiting macrophage ferroptosis via the I3P/AHR/NRF2 signaling pathway},
journal = {International Immunopharmacology},
year = {2025},
volume = {165},
pages = {115393},
doi = {10.1016/j.intimp.2025.115393}
}
EUVIMED